CPD: Oral Contraception: Five important issues.

  • DR Slabbert Department of Obstetrics and Gynaecology, Stellenbosch University and Tygerberg Hospital, P O Box 19081, Tygerberg 7505
  • TF Kruger Department of Obstetrics and Gynaecology, Stellenbosch University and Tygerberg Hospital, P O Box 19081, Tygerberg 7505
  • PS Steyn Department of Obstetrics and Gynaecology, Stellenbosch University and Tygerberg Hospital, P O Box 19081, Tygerberg 7505

Abstract

The dosage of the hormones used in the combined oral contraceptive pill have, over the past 40 years, continually decreased in order to provide formulations with minimum side effects while still retaining efficacy.1-4 Women are concerned that long-term use of combined oral contraceptives (COCs) increases health risks (including an increased risk of cancer or cardiovascular disease). In this article we would like to highlight some of the above issues and some of the commonly asked questions. This would enable us to provide the necessary advice and guidance to our patients. Oral contraception is an area in the health sector where new products are constantly developed and this means that, to give patients the best available advice, general practitioners, pharmacists and gynaecologists need to stay abreast with the latest literature and developments. (SA Fam Pract 2005;47(1): 22-24)

Author Biographies

DR Slabbert, Department of Obstetrics and Gynaecology, Stellenbosch University and Tygerberg Hospital, P O Box 19081, Tygerberg 7505
MBChB.
TF Kruger, Department of Obstetrics and Gynaecology, Stellenbosch University and Tygerberg Hospital, P O Box 19081, Tygerberg 7505
MBChB, MPharmMed, MMed (O&G), FCOG (SA), FRCOG (London), MD.
PS Steyn, Department of Obstetrics and Gynaecology, Stellenbosch University and Tygerberg Hospital, P O Box 19081, Tygerberg 7505
MBChB, MMed (O&G), FCOG (SA), MPhil (Stell), DFFP (Lond).
Published
2005-02-01
Section
Review Articles